Prognostic and predictive value of gastric acid suppressants in the EORTC 1325/KEYNOTE-054 randomized phase III trial of pembrolizumab vs placebo in resected stage III melanoma

Bührer, Emanuel; Kicinski, Michal; Blank, Christian U.; Carlino, Matteo S.; Di Giacomo, Anna Maria; Kennedy, Oliver J.; Meshcheryakov, Andrey; Suciu, Stefan; Dalle, Stéphane; Khattak, Adnan; Boers-Sonderen, Marye; van Akkooi, Alexander C. J.; Larkin, James; Robert, Caroline; Mandala, Mario; Long, Georgina V.; Eggermont, Alexander M. M.; Grob, Jean-Jacques; van den Eertwegh, Alfonsus J. M.; Glassee, Nina; Rutkowski, Piotr; Puig, Susana; Haydon, Andrew M.; Sandhu, Shahneen; Schadendorf, Dirk; Atkinson, Victoria G.; Gutzmer, Ralf; Gandini, Sara; Ascierto, Paolo A.; Jamal, Rahima; Lorigan, Paul; Valpione, Sara

doi:10.1016/j.ejcskn.2025.100727

guest :: login DKFZ
		Search		Submit		Personalize Your alerts Your baskets Your searches		Help

Home > Publications database > Prognostic and predictive value of gastric acid suppressants in the EORTC 1325/KEYNOTE-054 randomized phase III trial of pembrolizumab vs placebo in resected stage III melanoma

Journal Article

DKFZ-2025-01794

Prognostic and predictive value of gastric acid suppressants in the EORTC 1325/KEYNOTE-054 randomized phase III trial of pembrolizumab vs placebo in resected stage III melanoma

Bührer, E. ; Glassee, N. ; Kicinski, M. ; Kennedy, O. J. ; Blank, C. U. ; Long, G. V. ; Atkinson, V. G. ; Dalle, S. ; Haydon, A. M. ; Meshcheryakov, A. ; Khattak, A. ; Carlino, M. S. ; Sandhu, S. ; Larkin, J. ; Puig, S. ; Ascierto, P. A. ; Rutkowski, P. ; Schadendorf, D.DKFZ* ; Boers-Sonderen, M. ; Di Giacomo, A. M. ; van den Eertwegh, A. J. M. ; Grob, J.-J. ; Gutzmer, R. ; Jamal, R. ; van Akkooi, A. C. J. ; Gandini, S. ; Valpione, S. ; Suciu, S. ; Robert, C. ; Eggermont, A. M. M. ; Lorigan, P. ; Mandala, M.

2025
Elsevier B.V. Amsterdam